留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

冠心病人群运动靶心率无氧阈法与心率储备法一致性评价

韩凌 刘强 刘业发 范晓绵 徐笛 侯永洪 王东伟 丁荣晶

韩凌, 刘强, 刘业发, 范晓绵, 徐笛, 侯永洪, 王东伟, 丁荣晶. 冠心病人群运动靶心率无氧阈法与心率储备法一致性评价[J]. 中华全科医学, 2023, 21(11): 1837-1840. doi: 10.16766/j.cnki.issn.1674-4152.003237
引用本文: 韩凌, 刘强, 刘业发, 范晓绵, 徐笛, 侯永洪, 王东伟, 丁荣晶. 冠心病人群运动靶心率无氧阈法与心率储备法一致性评价[J]. 中华全科医学, 2023, 21(11): 1837-1840. doi: 10.16766/j.cnki.issn.1674-4152.003237
HAN Ling, LIU Qiang, LIU Yefa, FAN Xiaomian, XU Di, HOU Yonghong, WANG Dongwei, DING Rongjing. Evaluation of the agreement between the anaerobic threshold and heart rate reserve methods of target exercise heart rate in a population with coronary artery disease[J]. Chinese Journal of General Practice, 2023, 21(11): 1837-1840. doi: 10.16766/j.cnki.issn.1674-4152.003237
Citation: HAN Ling, LIU Qiang, LIU Yefa, FAN Xiaomian, XU Di, HOU Yonghong, WANG Dongwei, DING Rongjing. Evaluation of the agreement between the anaerobic threshold and heart rate reserve methods of target exercise heart rate in a population with coronary artery disease[J]. Chinese Journal of General Practice, 2023, 21(11): 1837-1840. doi: 10.16766/j.cnki.issn.1674-4152.003237

冠心病人群运动靶心率无氧阈法与心率储备法一致性评价

doi: 10.16766/j.cnki.issn.1674-4152.003237
基金项目: 

河南省医学科技攻关计划联合共建项目 2018020774

详细信息
    通讯作者:

    丁荣晶,E-mail:drj2003@vip.163.com

  • 中图分类号: R541.4  R540.4

Evaluation of the agreement between the anaerobic threshold and heart rate reserve methods of target exercise heart rate in a population with coronary artery disease

  • 摘要:   目的  通过心肺运动试验(CPET)所得无氧阈靶心率与心率储备法所得靶心率进行比较,检验不同方法所得靶心率的一致性,以指导制定运动处方。方法纳入2013年1月—2020年1月郑州市中心医院和北京大学人民医院确诊冠心病患者324例,采集CPET检查测得的无氧阈对应心率、静息心率以及实测最大心率等数据。通过组内相关系数(ICC)和Bland Altman法,比较CPET测定的无氧阈靶心率法和心率储备法计算的运动靶心率的一致性。  结果  324例患者无氧阈靶心率为(101.1±15.8)次/min,50%、60%、70%强度心率储备法靶心率分别为(102.2±13.5)次/min、(109.1±14.2)次/min、(113.6±15.1)次/min,无氧阈靶心率与50%强度心率储备法靶心率比较,差异无统计学意义(P=0.183)。无氧阈靶心率与50%强度心率储备法靶心率一致性检验的ICC值为0.781,95% CI:0.727~0.824,P<0.001;Bland Altman评价结果显示无氧阈靶心率与50%强度心率储备法靶心率的比值为0.99±0.12,95%一致性界限(LOA)为0.755~1.220。根据性别、年龄(≥65岁和<65岁)、是否曾发生心肌梗死、是否应用β受体阻滞剂以及是否完全血运重建进行亚组分析,ICC值范围在0.737~0.811(均P<0.001),结果显示各组一致性均好。  结论  在冠心病人群中,50%强度心率储备法靶心率与无氧阈靶心率一致性较好,临床中在无法接触心肺运动试验时可作为替代方案。

     

  • 图  1  冠心病患者无氧阈靶心率与50%HRR靶心率一致性评价结果(Bland-Altman法)

    Figure  1.  Consistency evaluation results of anaerobic threshold target heart rate and 50%HRR target heart rate in patients with coronary heart disease (Bland-Altman method)

  • [1] Writing committee of the report on cardiovascular health and diseases in china. Report on cardiovascular health and diseases in China 2021: an updated summary[J]. Biomed Environ Sci, 2022, 35(7): 573-603.
    [2] 王青青, 陈碧华, 李擎, 等. 分级诊疗背景下构建"心脏康复在社区"全科诊疗路径的实施对策[J]. 中华全科医学, 2021, 19(11): 1888-1892. doi: 10.16766/j.cnki.issn.1674-4152.002193

    WANG Q Q, CHEN B H, LI Q, et al. Implementation strategies for constructing a clinical path of cardiac rehabilitation in the community for community general practice care under hierarchical medical system[J]. Chinese Journal of General Practice, 2021, 19(11): 1888-1892. doi: 10.16766/j.cnki.issn.1674-4152.002193
    [3] LOLLEY R, FORMAN D E. Cardiac rehabilitation and survival for ischemic heart disease[J]. Curr Cardiol Rep, 2021, 23(12): 184. doi: 10.1007/s11886-021-01616-x
    [4] SALZWEDEL A, JENSEN K, RAUCH B, et al. Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-Ⅱ)[J]. Eur J Prev Cardiol, 2020, 27(16): 1756-1774. doi: 10.1177/2047487320905719
    [5] VILELA E M, LADEIRAS-LOPES R, JOAO A, et al. Current role and future perspectives of cardiac rehabilitation in coronary heart disease[J]. World J Cardiol, 2021, 13(12): 695-709. doi: 10.4330/wjc.v13.i12.695
    [6] GONÇALVES C, RAIMUNDO A, ABREU A, et al. Exercise intensity in patients with cardiovascular diseases: systematic review with meta-analysis[J]. Int J Environ Res Public Health, 2021, 18(7): 3574. doi: 10.3390/ijerph18073574
    [7] HANSEN D, ABREU A, AMBROSETTI M, et al. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology[J]. Eur J Prev Cardiol, 2022, 29(1): 230-245. doi: 10.1093/eurjpc/zwab007
    [8] MEZZANI A, HAMM L F, JONES A M, et al. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation[J]. Eur J Prev Cardiol, 2013, 20(3): 442-467. doi: 10.1177/2047487312460484
    [9] AMORIM H, CADILHA R, PARADA F, et al. Progression of aerobic exercise intensity in a cardiac rehabilitation program[J]. Rev Port Cardiol (Engl Ed), 2019, 38(4): 281-286. doi: 10.1016/j.repc.2018.07.009
    [10] PYMER S, NICHOLS S, PROSSER J, et al. Does exercise prescription based on estimated heart rate training zones exceed the ventilatory anaerobic threshold in patients with coronary heart disease undergoing usual-care cardiovascular rehabilitation? A United Kingdom perspective[J]. Eur J Prev Cardiol, 2020, 27(6): 579-589. doi: 10.1177/2047487319852711
    [11] SEMPER H, KÜHNELT P, SEIPP P. Cardiopulmonary exercise testing-step by step[J]. Dtsch Med Wochenschr, 2019, 144(1): 39-45. doi: 10.1055/a-0600-9233
    [12] MARCADET D M. Exercise testing: new guidelines[J]. Presse Med, 2019, 48(12): 1387-1392. doi: 10.1016/j.lpm.2019.09.011
    [13] AMBROSETTI M, ABREU A, CORRÀ U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the secondary prevention and rehabilitation section of the european association of preventive cardiology[J]. Eur J Prev Cardiol, 2021, 28(5): 460-495. doi: 10.1177/2047487320913379
    [14] TAYLOR J L, BONIKOWSKE A R, OLSON T P. Optimizing outcomes in cardiac rehabilitation: the importance of exercise intensity[J]. Front Cardiovasc Med, 2021, 8: 734278. DOI: 10.3389/fcvm.2021.734278.
    [15] 《药学与临床研究》编辑部. 如何正确运用组内相关系数进行一致性检验: 药物研究中的统计学(一)[J]. 药学与临床研究, 2018, 26(1): 78.

    Pharmaceutical and Clinical Research Editorial Department. How to correctly use intra-group correlation coefficient for consistency test-Statistics in drug research[J]. Pharmaceutical and Clinical Research, 2018, 26(1): 78.
    [16] CHEN T, ZHU H, SU Q. Effectiveness and safety of four aerobic exercise intensity prescription techniques in rehabilitation training for patients with coronary heart disease[J]. Cardiol Res Pract, 2022, 2022: 1647809. DOI: 10.1155/2022/1647809.
    [17] DÍAZ-BUSCHMANN I, JAUREGUIZAR K V, CALERO M J, et al. Programming exercise intensity in patients on beta-blocker treatment: the importance of choosing an appropriate method[J]. Eur J Prev Cardiol, 2014, 21(12): 1474-1480. doi: 10.1177/2047487313500214
    [18] HANSEN D, BONNÉ K, ALDERS T, et al. Exercise training intensity determination in cardiovascular rehabilitation: should the guidelines be reconsidered?[J]. Eur J Prev Cardiol, 2019, 26(18): 1921-1928. doi: 10.1177/2047487319859450
    [19] ZANETTINI R, CENTELEGHE P, RATTI F, et al. Training prescription in patients on beta-blockers: percentage peak exercise methods or self-regulation?[J]. Eur J Prev Cardiol, 2012, 19(2): 205-212. doi: 10.1177/1741826711398823
    [20] DADOVA K, SLABY K, RADVANSKY J, et al. Exercise prescription in cardiac patients treated with metoprolol-should the time of day for stress tests and training coincide?[J]. Eur J Prev Cardiol, 2018, 25(10): 1026-1027. doi: 10.1177/2047487318771776
  • 加载中
图(1)
计量
  • 文章访问数:  155
  • HTML全文浏览量:  142
  • PDF下载量:  12
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-03-12
  • 网络出版日期:  2024-01-13

目录

    /

    返回文章
    返回